Followers | 29 |
Posts | 2446 |
Boards Moderated | 0 |
Alias Born | 11/22/2010 |
Friday, December 29, 2017 6:19:11 AM
I do not think company insiders are involved in any fraud. Zero, Ziltch.
Financiers... not frauds, just prudent selling on silly pops on well engineered press releases. *I also know of around 150K-200K worth of retail shares that investors dumped after $7.50s didn't hold and we opened under $6.00 the next day. many of these shares were sold at a loss from LONG term holds. They basically finally said "enough is enough, I'll book a loss here against gains elsewhere and never come back to this POS company"
what that last PR should have said was
"Fantastic News!! Data rocks ( which it did ).. Bad news is we didn't get a satisfactory offer which represented value to legacy share holders so we decided to give interested parties ($MON) more time to do critical testing on core cash crops ( Soybean ).
In the meantime, we are pretty stuffed for any cash and will BK if we don't find some soon. So we are going to do a raise"
fast forward a week they should have said
"Sorry folks, we really tried hard and pursued every possible avenue for financing operations over the next year. Unfortunately, we are down to the wire and had to accept this crappy dilution, warrants, deal. Our only hope is that we pull a low % bet CRISPR discovery out of the bag over the next year. If we do, We will back over $10 in no time. If not, sorry folks but think $4-$6 is about as high as you can ever expect an offer from $MON to be."
But of course, even if someone in the company wanted to be that honest; Financiers would not fathom this sort of transparency
All just my opinion. of course.
the new Share structure. It's ~Toxic IMO
you never know how far it's gonna go and when the run is going to end. So sell whole way up, hang onto 25%-40% and then you see the weakness begin. dump the rest 10%-20% off the top.
all just my opinion, of course
Recent YTEN News
- Yield10 Bioscience Announces 1-for-24 Reverse Stock Split • GlobeNewswire Inc. • 05/01/2024 12:30:00 PM
- Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 04/01/2024 08:01:07 PM
- Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024 • GlobeNewswire Inc. • 03/28/2024 08:01:20 PM
- Yield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canada • GlobeNewswire Inc. • 03/26/2024 12:29:24 PM
- USDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United States • GlobeNewswire Inc. • 03/21/2024 12:29:14 PM
- Yield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field Tests • GlobeNewswire Inc. • 02/29/2024 01:31:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 09:37:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 03:09:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:29:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:26:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 11:25:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 05:45:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 04:34:18 PM
- Yield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel Feedstock • GlobeNewswire Inc. • 02/14/2024 02:00:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 10:19:22 PM
- Yield10 Bioscience Provides an Update on its Omega-3 Camelina Program • GlobeNewswire Inc. • 02/07/2024 10:40:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 02:47:54 AM
- Yield10 Bioscience Files Request for Regulatory Status Review with USDA-APHIS for Camelina Designed to Produce the EPA and DHA Components of Omega-3 Oil • GlobeNewswire Inc. • 01/08/2024 01:31:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:35:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:29:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/06/2023 09:11:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/17/2023 09:27:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:59:53 PM
- USDA-APHIS Determines that Yield10 Bioscience’s Stacked Herbicide Tolerant Camelina May Be Planted and Bred in the United States • GlobeNewswire Inc. • 11/15/2023 01:32:19 PM
- USDA-APHIS Determines that Yield10 Bioscience’s Glufosinate Tolerant Camelina May Be Planted and Bred in the United States • GlobeNewswire Inc. • 11/15/2023 01:31:34 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM